# Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter

> **NCT02453646** · NA · COMPLETED · sponsor: **Marvao Medical** · enrollment: 120 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** NexSite HD Patients

## Key facts

- **NCT ID:** NCT02453646
- **Lead sponsor:** Marvao Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2017-09
- **Final completion:** 2018-07
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02453646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02453646, "Analysis of CRBSI Rates in Patients With a NexSite™ HD (Hemodialysis) Catheter". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02453646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*